Levetiracetam 1000 MG Oral Tablet
1 INDICATIONS AND USAGE Levetiracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) Levetiracetam tablets are indicated for adjunctive therapy for the treatment of: • Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy ( 1.2 ) • Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy ( 1.3 ) 1.1 Partial-Onset Seizures Levetiracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. 1.2 Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy Levetiracetam tablets are indicated as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy. 1.3 Primary Generalized Tonic-Clonic Seizures Levetiracetam tablets are indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.
camber pharmaceuticals, inc.
OVAL WHITE H 91
Related Pills
Levetiracetam 750 MG Oral Tablet
Camber Pharmaceuticals
levetiracetam tablet film coated
camber pharmaceuticals
candesartan cilexetil 16 mg
American Health Packaging
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
LEVETIRACETAM tablets USP, 250 mg are blue colored, oblong shaped, scored, film coated tablets debossed with 'H' on one side and '87' on other side. They are supplied in containers of 30 tablets (NDC 31722-536-30) 60 tablets (NDC 31722-536-60) 120 tablets (NDC 31722-536-12) 500 tablets (NDC 31722-536-05) 1000 tablets (NDC 31722-536-10)
LEVETIRACETAM tablets USP, 500 mg are yellow colored, oblong shaped, scored, film coated tablets debossed with 'H' on one side and '88' on other side. They are supplied in containers of 30 tablets (NDC 31722-537-30) 60 tablets (NDC 31722-537-60) 120 tablets (NDC 31722-537-12) 500 tablets (NDC 31722-537-05) 1000 tablets (NDC 31722-537-10)
LEVETIRACETAM tablets USP, 750 mg are orange colored, oblong shaped, scored, film coated tablets debossed with 'H' on one side and '90' on other side. They are supplied in containers of 30 tablets (NDC 31722-538-30) 60 tablets (NDC 31722-538-60) 120 tablets (NDC 31722-538-12) 500 tablets (NDC 31722-538-05)
LEVETIRACETAM tablets USP, 1000 mg are white colored, oblong shaped, scored, film coated tablets debossed with 'H' on one side and '91' on other side. They are supplied in containers of 30 tablets (NDC 31722-539-30) 60 tablets (NDC 31722-539-60) 120 tablets (NDC 31722-539-12) 500 tablets (NDC 31722-539-05) 16.2 Storage Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
More pills like OVAL H 91